AYTU
Aytu BioPharma·NASDAQ
--
--(--)
--
--(--)
AYTU fundamentals
Aytu BioPharma (AYTU) released its earnings on Feb 3, 2026: revenue was 15.20M (YoY -6.29%), beat estimates; EPS was -1.05 (YoY -275.00%), missed estimates.
Revenue / YoY
15.20M
-6.29%
EPS / YoY
-1.05
-275.00%
Report date
Feb 3, 2026
AYTU Earnings Call Summary for Q2,2026
- EXXUA Early Success: 100+ prescribers wrote scripts in 30 days, with positive patient feedback on tolerability.
- ADHD Resilience: $13.2M revenue stable YoY, RxConnect mitigates generic competition impact.
- Financial Challenges: Q2 net loss $10.6M due to EXXUA launch costs, targeting breakeven at $17.3M/Q.
- Strategic Focus: Cautious sales expansion, limited DTC efforts, ample supply to meet demand.
EPS
Revenue
Revenue & Expenses
AYTU has released its 2026 Q2 earnings report, with revenue of 15.16M, reflecting a YoY change of -6.51%, and net profit of -10.58M, showing a YoY change of -1443.15%. The Sankey diagram below clearly presents AYTU's revenue sources and cost distribution.
Key Indicators
Aytu BioPharma (AYTU) key financial stats and ratios, covering profitability, financial health, and leverage.
Aytu BioPharma (AYTU)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Aytu BioPharma (AYTU)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Aytu BioPharma (AYTU)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Aytu BioPharma (AYTU) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Aytu BioPharma (AYTU) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Aytu BioPharma's latest dividend and current dividend yield?What does Aytu BioPharma do and what are its main business segments?What is the market's earnings forecast for Aytu BioPharma next quarter?What guidance did Aytu BioPharma's management provide for the next earnings period?What is Aytu BioPharma's gross profit margin?What is the revenue and EPS growth rate for Aytu BioPharma year over year?What factors drove the changes in Aytu BioPharma's revenue and profit?What were the key takeaways from Aytu BioPharma's earnings call?
